InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by WORLAND STEPHEN T, Chairman & CEO. Director active across 1 companies, notably eFFECTOR Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Total volume traded: €26k. The latest transaction was filed on 7 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€25,61120,000 shares@ €1.280590.4% of flow
Common Stock
SEC:0001209191-22-035277:0·
Ideal exit: 4 Mar 2023 (T+270)
€2,7081,837 shares@ €1.4749.6% of flow
Common Stock
SEC:0001209191-22-029890:0·
512,339 shares
Common Stock
SEC:0001209191-21-053686·
512,339 shares
Common Stock
SEC:0001209191-21-053686:0·
4 of 4 declarations
About WORLAND STEPHEN T
Worland Stephen T is the Chairman and CEO of eFFECTOR Therapeutics, Inc. He leads the company with a focus on developing innovative therapies for cancer treatment. His leadership and strategic vision are essential in guiding eFFECTOR's research and development efforts aimed at improving patient outcomes.
